ID   PK0809
AC   CVCL_C0Z3
SY   PK-0809; PK 0809; PK 032495; PK032495
DR   Wikidata; Q114312660
RX   Patent=US5911999;
RX   PubMed=17494075;
RX   PubMed=24398227;
CC   From: Draayer H.A.; Beecham Laboratories; Whitehall; USA.
CC   Miscellaneous: Identity of PK0809 with PK032495 and origin of cell line from personal commuincation of Calvert J.G.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
RX   Patent=US5911999;
RA   Bordt D.E., Draayer H.A.;
RT   "Vaccine based on TGEV for protection of dogs against canine coronavirus.";
RL   Patent number US5911999, 15-Jun-1999.
//
RX   PubMed=17494075; DOI=10.1128/JVI.00513-07;
RA   Calvert J.G., Slade D.E., Shields S.L., Jolie R., Mannan R.M.,
RA   Ankenbauer R.G., Welch S.-K.W.;
RT   "CD163 expression confers susceptibility to porcine reproductive and
RT   respiratory syndrome viruses.";
RL   J. Virol. 81:7371-7379(2007).
//
RX   PubMed=24398227; DOI=10.1016/j.vetmic.2013.12.001;
RA   Lithgow P.E., Takamatsu H., Werling D., Dixon L.K., Chapman D.;
RT   "Correlation of cell surface marker expression with African swine
RT   fever virus infection.";
RL   Vet. Microbiol. 168:413-419(2014).
//